GPR183: Difference between revisions
CSV import |
CSV import |
||
| Line 24: | Line 24: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 13:14, 17 March 2025
GPR183 (G Protein-Coupled Receptor 183), also known as EBI2 (Epstein-Barr Virus Induced Gene 2), is a protein that in humans is encoded by the GPR183 gene. It is a member of the G protein-coupled receptor family and plays a crucial role in the immune system.
Function[edit]
GPR183 is a G protein-coupled receptor that is involved in the regulation of B cell function. It is expressed in various tissues with high levels in lymphoid tissues such as spleen, lymph node, and peripheral blood leukocytes. The receptor is activated by a lipid molecule called 7α,25-dihydroxycholesterol (7α,25-OHC) which is synthesized in response to inflammatory signals. This activation leads to the migration of B cells and other immune cells to the inflamed tissues.
Clinical Significance[edit]
Alterations in the GPR183 gene have been associated with various diseases. Overexpression of GPR183 has been observed in Hodgkin's lymphoma and diffuse large B cell lymphoma, suggesting a potential role in the pathogenesis of these diseases. In addition, GPR183 has been implicated in autoimmune diseases such as multiple sclerosis and systemic lupus erythematosus.
Research[edit]
Research is ongoing to understand the precise role of GPR183 in the immune system and its potential as a therapeutic target. Studies have shown that blocking the activity of GPR183 can reduce the severity of autoimmune diseases in animal models, suggesting a potential therapeutic strategy for these conditions.
See Also[edit]
References[edit]
<references />
